323 related articles for article (PubMed ID: 21902810)
1. Extracellular TG2: emerging functions and regulation.
Belkin AM
FEBS J; 2011 Dec; 278(24):4704-16. PubMed ID: 21902810
[TBL] [Abstract][Full Text] [Related]
2. Physiological, pathological, and structural implications of non-enzymatic protein-protein interactions of the multifunctional human transglutaminase 2.
Kanchan K; Fuxreiter M; Fésüs L
Cell Mol Life Sci; 2015 Aug; 72(16):3009-35. PubMed ID: 25943306
[TBL] [Abstract][Full Text] [Related]
3. Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses.
Stephens P; Grenard P; Aeschlimann P; Langley M; Blain E; Errington R; Kipling D; Thomas D; Aeschlimann D
J Cell Sci; 2004 Jul; 117(Pt 15):3389-403. PubMed ID: 15199098
[TBL] [Abstract][Full Text] [Related]
4. Transglutaminase 2 interacts with syndecan-4 and CD44 at the surface of human macrophages to promote removal of apoptotic cells.
Nadella V; Wang Z; Johnson TS; Griffin M; Devitt A
Biochim Biophys Acta; 2015 Jan; 1853(1):201-12. PubMed ID: 25449226
[TBL] [Abstract][Full Text] [Related]
5. Transglutaminase 2 as a novel activator of LRP6/β-catenin signaling.
Deasey S; Nurminsky D; Shanmugasundaram S; Lima F; Nurminskaya M
Cell Signal; 2013 Dec; 25(12):2646-51. PubMed ID: 23993960
[TBL] [Abstract][Full Text] [Related]
6. Characterization of heparin-binding site of tissue transglutaminase: its importance in cell surface targeting, matrix deposition, and cell signaling.
Wang Z; Collighan RJ; Pytel K; Rathbone DL; Li X; Griffin M
J Biol Chem; 2012 Apr; 287(16):13063-83. PubMed ID: 22298777
[TBL] [Abstract][Full Text] [Related]
7. The role of tissue transglutaminase in cell-matrix interactions.
Zemskov EA; Janiak A; Hang J; Waghray A; Belkin AM
Front Biosci; 2006 Jan; 11():1057-76. PubMed ID: 16146797
[TBL] [Abstract][Full Text] [Related]
8. RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signaling.
Wang Z; Collighan RJ; Gross SR; Danen EH; Orend G; Telci D; Griffin M
J Biol Chem; 2010 Dec; 285(51):40212-29. PubMed ID: 20929862
[TBL] [Abstract][Full Text] [Related]
9. A novel extracellular role for tissue transglutaminase in matrix-bound VEGF-mediated angiogenesis.
Wang Z; Perez M; Caja S; Melino G; Johnson TS; Lindfors K; Griffin M
Cell Death Dis; 2013 Sep; 4(9):e808. PubMed ID: 24052076
[TBL] [Abstract][Full Text] [Related]
10. Size distribution and molecular associations of plasma fibronectin and fibronectin crosslinked by transglutaminase 2.
Nelea V; Nakano Y; Kaartinen MT
Protein J; 2008 Jun; 27(4):223-33. PubMed ID: 18330684
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis.
Tatsukawa H; Kojima S
Cell Biol Int; 2010 Feb; 34(3):325-34. PubMed ID: 20192918
[TBL] [Abstract][Full Text] [Related]
12. The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.
Kotsakis P; Wang Z; Collighan RJ; Griffin M
Amino Acids; 2011 Oct; 41(4):909-21. PubMed ID: 21046178
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminase 2 strongly binds to an extracellular matrix component other than fibronectin via its second C-terminal beta-barrel domain.
Stamnaes J; Cardoso I; Iversen R; Sollid LM
FEBS J; 2016 Nov; 283(21):3994-4010. PubMed ID: 27685605
[TBL] [Abstract][Full Text] [Related]
14. Heparan sulfate proteoglycans are receptors for the cell-surface trafficking and biological activity of transglutaminase-2.
Scarpellini A; Germack R; Lortat-Jacob H; Muramatsu T; Billett E; Johnson T; Verderio EA
J Biol Chem; 2009 Jul; 284(27):18411-23. PubMed ID: 19398782
[TBL] [Abstract][Full Text] [Related]
15. Role of protein modifications mediated by transglutaminase 2 in human viral diseases.
Jeon JH; Kim IG
Front Biosci; 2006 Jan; 11():221-31. PubMed ID: 16146727
[TBL] [Abstract][Full Text] [Related]
16. Insights into the heparan sulphate-dependent externalisation of transglutaminase-2 (TG2) in glucose-stimulated proximal-like tubular epithelial cells.
Furini G; Burhan I; Huang L; Savoca MP; Atobatele A; Johnson T; Verderio EAM
Anal Biochem; 2020 Aug; 603():113628. PubMed ID: 32074489
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization.
Gundemir S; Colak G; Feola J; Blouin R; Johnson GV
Biochim Biophys Acta; 2013 Jan; 1833(1):1-10. PubMed ID: 23085038
[TBL] [Abstract][Full Text] [Related]
18. Activation of extracellular transglutaminase 2 by mechanical force in the arterial wall.
Huelsz-Prince G; Belkin AM; VanBavel E; Bakker EN
J Vasc Res; 2013; 50(5):383-95. PubMed ID: 23988702
[TBL] [Abstract][Full Text] [Related]
19. Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancer.
Yakubov B; Chelladurai B; Schmitt J; Emerson R; Turchi JJ; Matei D
Neoplasia; 2013 Jun; 15(6):609-19. PubMed ID: 23730209
[TBL] [Abstract][Full Text] [Related]
20. The role of transglutaminase-2 and its substrates in human diseases.
Facchiano F; Facchiano A; Facchiano AM
Front Biosci; 2006 May; 11():1758-73. PubMed ID: 16368554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
